209 related articles for article (PubMed ID: 29695567)
1. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy.
Sato S; Kunisaki C; Suematsu H; Tanaka Y; Miyamoto H; Kosaka T; Yukawa N; Tanaka K; Sato K; Akiyama H; Endo I
In Vivo; 2018; 32(3):603-610. PubMed ID: 29695567
[TBL] [Abstract][Full Text] [Related]
2. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
[TBL] [Abstract][Full Text] [Related]
3. Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.
Huang CH; Lue KH; Hsieh TC; Liu SH; Wang TF; Peng TC
Anticancer Res; 2020 Feb; 40(2):1175-1181. PubMed ID: 32014971
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?
Saeki H; Nakashima Y; Kudou K; Sasaki S; Jogo T; Hirose K; Edahiro K; Korehisa S; Taniguchi D; Nakanishi R; Kubo N; Ando K; Kabashima A; Oki E; Maehara Y
World J Surg; 2018 Sep; 42(9):2894-2901. PubMed ID: 29488065
[TBL] [Abstract][Full Text] [Related]
6. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
7. Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.
Koch C; Reitz C; Schreckenbach T; Eichler K; Filmann N; Al-Batran SE; Götze T; Zeuzem S; Bechstein WO; Kraus T; Bojunga J; Düx M; Trojan J; Blumenstein I
PLoS One; 2019; 14(10):e0223613. PubMed ID: 31639132
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.
Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C
Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
Furuta M; Yokota T; Tsushima T; Todaka A; Machida N; Hamauchi S; Yamazaki K; Fukutomi A; Kawai S; Kawabata T; Onozawa Y; Yasui H
Jpn J Clin Oncol; 2019 Oct; 49(10):910-918. PubMed ID: 31219161
[TBL] [Abstract][Full Text] [Related]
10. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
11. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer.
Ida S; Watanabe M; Yoshida N; Baba Y; Umezaki N; Harada K; Karashima R; Imamura Y; Iwagami S; Baba H
Ann Surg Oncol; 2015 Dec; 22(13):4432-7. PubMed ID: 25862583
[TBL] [Abstract][Full Text] [Related]
14. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
Jogiat UM; Bédard ELR; Sasewich H; Turner SR; Eurich DT; Filafilo H; Baracos V
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2630-2636. PubMed ID: 36151845
[TBL] [Abstract][Full Text] [Related]
16. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.
Paireder M; Asari R; Kristo I; Rieder E; Tamandl D; Ba-Ssalamah A; Schoppmann SF
Eur J Surg Oncol; 2017 Feb; 43(2):478-484. PubMed ID: 28024944
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
[TBL] [Abstract][Full Text] [Related]
18. Esophageal bypass operation prior to definitive chemoradiotherapy in advanced esophageal cancer with tracheobronchial invasion.
Hihara J; Hamai Y; Emi M; Aoki Y; Taomoto J; Miyata Y; Okada M
Ann Thorac Surg; 2014 Jan; 97(1):290-5. PubMed ID: 24200399
[TBL] [Abstract][Full Text] [Related]
19. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
20. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
Hurmuzlu M; Monge OR; Smaaland R; Viste A
Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
